Paul Tudor Jones's TNGX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 68,251 shares of Tango Therapeutics, Inc. (TNGX) worth $604,704, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in TNGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 63,296 shares. Largest reduction occurred in Q2 2024, reducing 50,894 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Tango Therapeutics (TNGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tango Therapeutics (TNGX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +14,679 | Add 27.40% | 68,251 | $8.86 |
| Q3 2025 | +53,572 | New Buy | 53,572 | $8.40 |
| Q2 2025 | -34,060 | Sold Out | 0 | $0.00 |
| Q1 2025 | -26,554 | Reduce 43.81% | 34,060 | $1.37 |
| Q4 2024 | -2,682 | Reduce 4.24% | 60,614 | $3.09 |
| Q3 2024 | +63,296 | New Buy | 63,296 | $7.70 |
| Q2 2024 | -50,894 | Sold Out | 0 | $0.00 |
| Q1 2024 | -1,211 | Reduce 2.32% | 50,894 | $7.94 |
| Q4 2023 | +52,105 | New Buy | 52,105 | $9.90 |
Paul Tudor Jones's Tango Therapeutics Investment FAQs
Paul Tudor Jones first purchased Tango Therapeutics, Inc. (TNGX) in Q4 2023, acquiring 52,105 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Tango Therapeutics, Inc. (TNGX) for 9 quarters since Q4 2023.
Paul Tudor Jones's largest addition to Tango Therapeutics, Inc. (TNGX) was in Q3 2024, adding 63,296 shares worth $487,379.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 68,251 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $604,704.
As of the Q4 2025 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Tango Therapeutics, Inc. (TNGX) was 68,251 shares, as reported at the end of Q4 2025.